HanseMerkur Center for Traditional Chinese Medicine at the University Medical Center Hamburg-Eppendorf, W20, Martinistrasse 64, Hamburg 22351, Germany.
Longhua Hospital Affiliated to Shanghai TCM-University, Shanghai, China.
Phytomedicine. 2022 Sep;104:154294. doi: 10.1016/j.phymed.2022.154294. Epub 2022 Jun 26.
Chemotherapy-induced peripheral neuropathy (CIPN) is recognized as the second commonest side effect after chemotherapy. Besides neurological deficits and pain, it is a potential reason for terminating chemotherapy. Effective curative treatments of neurodegeneration are lacking. Hitherto, no randomized controlled study used nerve conduction studies (NCS), the gold standard diagnostic tool for peripheral neuropathy, as the primary outcome parameter for evaluating acupuncture for CIPN, which can also measure structural changes.
The study was carried out at the HanseMerkur Center for TCM at the University Medical Center, Hamburg-Eppendorf. Sixty patients with CIPN were included in the study after physical examination, subjective evaluation and quantitative evaluation by NCS. Subsequently, the patients were randomly assigned to Group 1 (30 patients), which received, in the first period, needle acupuncture and to Group 2 (30 patients), which was assigned to the waiting list in the first period. Group 1 received a standard 10-week bilateral treatment of ST34 (Liangqiu), EX-LE12 (Qiduan) and EX-LE8 (Bafeng). After 14 weeks, both groups were re-evaluated. Using a cross-over design, the patients of Group 2 received the same treatment procedure as Group 1 in the first period. Patients of Group 1 were assigned to the waiting list for the second period. After 28 weeks both groups were re-evaluated. Wilcoxon test was used as a pre-test to rule out carryover effects and to test for differences between acupuncture and the waiting list. Group assignment was not exposed to the statistician and the neurologist.
Sural sensory nerve amplitude, and sural nerve conduction velocity, were significantly improved (p < 0.01, effect size (f) 0.55 and 0.49) compared to measurements in the waiting period. Change of NCS of the tibial nerve did not significantly differ in group comparison. Patients reported subjective improvement during acupuncture treatment superior to the waiting period for burning pain, cramps, numbness, frequency of symptoms (all p < 0.01) and unsteadiness of gait (p < 0.05). On physical examination, blind walking, heel-to-toe walking, distal pallhypesthesia (both p < 0.01), and the neuropathy deficit score (p < 0.05) were significantly improved during acupuncture treatment compared to the waiting period.
Acupuncture can enhance structural regeneration in CIPN as measured by NCS, which is manifested in subjective improvement and neurological findings.
化疗引起的周围神经病(CIPN)是继化疗后第二常见的副作用。除了神经功能缺损和疼痛外,它也是终止化疗的一个潜在原因。目前还缺乏有效的神经退行性疾病治疗方法。迄今为止,尚无随机对照研究使用神经传导研究(NCS)作为评估 CIPN 针刺的主要疗效参数,NCS 是周围神经病的金标准诊断工具,也可测量结构变化。
该研究在汉堡-埃彭多夫大学医学中心的汉萨默克中心中医进行。60 例 CIPN 患者在体检、主观评估和 NCS 定量评估后纳入研究。随后,患者被随机分配到第 1 组(30 例),第 1 期接受针刺治疗,第 2 组(30 例)在第 1 期进入等待名单。第 1 组接受双侧 ST34(梁丘)、EX-LE12(曲泉)和 EX-LE8(八风)标准 10 周治疗。14 周后,两组均进行重新评估。采用交叉设计,第 2 组患者在第 1 期接受与第 1 组相同的治疗程序。第 1 组患者被分配到第 2 期的等待名单。28 周后,两组均进行重新评估。采用 Wilcoxon 检验作为预检验,以排除交叉效应,并检验针刺与等待名单之间的差异。组分配对统计学家和神经科医生是保密的。
与等待期相比,感觉神经传导速度和感觉神经传导速度均显著改善(p <0.01,效应量(f)为 0.55 和 0.49)。与组间比较相比,胫神经 NCS 变化无显著差异。患者在针刺治疗期间报告的主观改善优于等待期的烧灼感、痉挛、麻木、症状频率(均 p <0.01)和步态不稳(p <0.05)。在体检中,与等待期相比,盲走、脚跟到脚趾走、远端感觉减退(均 p <0.01)和神经病变缺陷评分(p <0.05)在针刺治疗期间显著改善。
针刺治疗可以增强 CIPN 的结构再生,这可以通过 NCS 测量得到证实,表现为主观改善和神经学发现。